Revolucione sua formulação de medicamentos com nossa solução de 3-etil-5-metil-4-(2-clorofenil)-2-(2,2-detoxi-etoximetil)-6-metil-1,4-di-hidropiridina-3,5-dicarboxilato CAS 103094-30-0

Visão geral do produto

This comprehensive guide aims to revolutionize your drug formulation process with our innovative 3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-ethoxymethyl)-6-Methyl-1,4-Dihydropyridine-3,5-Dicarboxylate CAS 103094-30-0 Solution. This article will delve into the details of the product, its parameters, usage scenarios, case studies, and expert guidance to ensure you make the most out of this solution.

Resumo do produto

This guide provides an in-depth analysis of our 3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-ethoxymethyl)-6-Methyl-1,4-Dihydropyridine-3,5-Dicarboxylate CAS 103094-30-0 Solution. It covers product parameters, usage scenarios, case studies, and expert guidance to help you optimize your drug formulation process. By the end of this guide, you will have a comprehensive understanding of how this solution can revolutionize your drug formulation.

Parâmetros do produto

Our 3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-ethoxymethyl)-6-Methyl-1,4-Dihydropyridine-3,5-Dicarboxylate CAS 103094-30-0 Solution is a white to off-white crystalline powder. It has a melting point of 150-155°C and a solubility of 1mg/mL in DMSO. The molecular weight of the compound is 434.88 g/mol, and its molecular formula is C₁₈H₁₆ClNO₅.

Cenários de utilização

This solution is widely used in the pharmaceutical industry for the synthesis of various drugs. It is particularly effective in the development of cardiovascular, antihypertensive, and anticoagulant drugs. The compound's unique structure and properties make it an ideal choice for drug formulation in these areas.

Estudos de caso

Estudo de caso 1: Empresa A

Company A, a leading pharmaceutical company, used our solution to develop a new antihypertensive drug. The drug was successfully synthesized using our solution, and it has since been approved by regulatory authorities. The drug has shown promising results in clinical trials, and it is expected to be launched in the market soon.

Estudo de caso 2: Empresa B

Company B, a small biotech firm, used our solution to develop a novel cardiovascular drug. The drug was synthesized using our solution, and it has shown promising results in preclinical studies. The company is currently in the process of conducting clinical trials to further evaluate the drug's efficacy and safety.

Solução

Our 3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-ethoxymethyl)-6-Methyl-1,4-Dihydropyridine-3,5-Dicarboxylate CAS 103094-30-0 Solution offers a unique solution for drug formulation. Its unique structure and properties make it an ideal choice for the development of cardiovascular, antihypertensive, and anticoagulant drugs. By using this solution, you can optimize your drug formulation process and develop innovative drugs that meet the needs of patients worldwide.

Orientação especializada

Our team of experts is available to provide guidance on the use of our 3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-ethoxymethyl)-6-Methyl-1,4-Dihydropyridine-3,5-Dicarboxylate CAS 103094-30-0 Solution. We can help you understand the product's properties, optimize your drug formulation process, and develop innovative drugs that meet the needs of patients worldwide.

Conclusão

In conclusion, our 3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-ethoxymethyl)-6-Methyl-1,4-Dihydropyridine-3,5-Dicarboxylate CAS 103094-30-0 Solution is a revolutionary product that can transform your drug formulation process. Its unique structure and properties make it an ideal choice for the development of cardiovascular, antihypertensive, and anticoagulant drugs. By using this solution, you can optimize your drug formulation process and develop innovative drugs that meet the needs of patients worldwide.

Palavras-chave

3-Ethyl-5-Methyl-4-(2-Chlorophenyl)-2-(2,2-Diethoxy-ethoxymethyl)-6-Methyl-1,4-Dihydropyridine-3,5-Dicarboxylate, drug formulation, cardiovascular drugs, antihypertensive drugs, anticoagulant drugs

Enviar pedido de informação

Para mais informações ou para efetuar uma encomenda, envie um pedido de informação para info@allguide.org.

FQA

Q: What is the melting point of the compound?

A: The melting point of the compound is 150-155°C.

Q: What is the solubility of the compound in DMSO?

R: A solubilidade do composto em DMSO é de 1mg/mL.

Q: What is the molecular weight of the compound?

A: The molecular weight of the compound is 434.88 g/mol.